These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30526140)

  • 1. Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis.
    Inchingolo R; Varone F; Sgalla G; Richeldi L
    Expert Rev Respir Med; 2019 Jan; 13(1):39-51. PubMed ID: 30526140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in idiopathic pulmonary fibrosis.
    Drakopanagiotakis F; Wujak L; Wygrecka M; Markart P
    Matrix Biol; 2018 Aug; 68-69():404-421. PubMed ID: 29408012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine in idiopathic pulmonary fibrosis: facts and promises.
    Spagnolo P; Tzouvelekis A; Maher TM
    Curr Opin Pulm Med; 2015 Sep; 21(5):470-8. PubMed ID: 26132817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers.
    Hambly N; Shimbori C; Kolb M
    Respirology; 2015 Oct; 20(7):1010-22. PubMed ID: 26109466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers and their potential functions in idiopathic pulmonary fibrosis.
    Ni S; Song M; Guo W; Guo T; Shen Q; Peng H
    Expert Rev Respir Med; 2020 Jun; 14(6):593-602. PubMed ID: 32187497
    [No Abstract]   [Full Text] [Related]  

  • 6. Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?
    Alfaro TM; Robalo Cordeiro C
    Ther Adv Respir Dis; 2020; 14():1753466620910092. PubMed ID: 32167024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions.
    Stainer A; Faverio P; Busnelli S; Catalano M; Della Zoppa M; Marruchella A; Pesci A; Luppi F
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis.
    Cameli P; Bergantini L; Salvini M; Refini RM; Pieroni M; Bargagli E; Sestini P
    Nitric Oxide; 2019 Aug; 89():41-45. PubMed ID: 31054949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Idiopatic pulmonary fibrosis - news in multidisciplinary diagnostic and therapeutic approaches].
    Vašáková M; Matěj R
    Cesk Patol; 2016; 52(2):85-92. PubMed ID: 27223586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers in the Evaluation and Management of Idiopathic Pulmonary Fibrosis.
    Tzouvelekis A; Herazo-Maya J; Sakamoto K; Bouros D
    Curr Top Med Chem; 2016; 16(14):1587-98. PubMed ID: 26420365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs.
    Hadjicharalambous MR; Lindsay MA
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic pulmonary fibrosis: pathogenesis and management.
    Sgalla G; Iovene B; Calvello M; Ori M; Varone F; Richeldi L
    Respir Res; 2018 Feb; 19(1):32. PubMed ID: 29471816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis.
    Maldonado M; Buendía-Roldán I; Vicens-Zygmunt V; Planas L; Molina-Molina M; Selman M; Pardo A
    PLoS One; 2018; 13(9):e0203779. PubMed ID: 30208119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biomarkers in idiopathic pulmonary fibrosis and disease severity.
    Crestani B
    Sarcoidosis Vasc Diffuse Lung Dis; 2013 Sep; 30 Suppl 1():27-32. PubMed ID: 24081241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis.
    Buendía-Roldán I; Ruiz V; Sierra P; Montes E; Ramírez R; Vega A; Salgado A; Vargas MH; Mejía M; Pardo A; Selman M
    PLoS One; 2016; 11(12):e0168552. PubMed ID: 27977812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of biomarkers in diagnosis and treatment of idiopathic pulmonary fibrosis].
    Fan Y; He R; Zou L; Meng J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1062-1065. PubMed ID: 32895164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biomarkers in idiopathic pulmonary fibrosis.
    Ley B; Brown KK; Collard HR
    Am J Physiol Lung Cell Mol Physiol; 2014 Nov; 307(9):L681-91. PubMed ID: 25260757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the diagnosis of idiopathic pulmonary fibrosis; the growing role of systems biology and stratified medicine.
    Maher TM
    Curr Opin Pulm Med; 2013 Sep; 19(5):460-5. PubMed ID: 23912190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Idiopathic pulmonary fibrosis. Can we always diagnose and treat it right?].
    Vašáková M
    Vnitr Lek; 2018; 63(11):796-801. PubMed ID: 29303281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.